TYMS and gastric cancer: For instance, MKI67 is a potential indicator to predict the prognosis of patients with stomach cancer and identify high-risk cases (Guo et al., 2018), and TYMS may be potential biomarkers for prognosis and chemotherapy guidance for stomach cancer (Cao et al., 2017).